We are live on ! Find out more
BLACU

Bellevue Life Sciences Acquisition Corp. Unit
BLACU

Delisted

BLACU was delisted on the 14th of February, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in Bellevue Life Sciences Acquisition Corp. Unit in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $61.3K → $0 (-$61.3K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CS
Clear Street
New York
-$55.6K
2
UBS Group
UBS Group
Switzerland
-$5.6K
3
TRCT
Tower Research Capital (TRC)
New York
-$116
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Clear Street
New York
– -$55.6K -4,679 Closed
UBS Group
2
UBS Group
Switzerland
– -$5.6K -500 Closed
TRCT
3
Tower Research Capital (TRC)
New York
– -$116 -10 Closed

BLACU Hedge Fund Activity: Q1 2025 in Review

0 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Unit (BLACU) for Q1 2025, worth a combined $0 — down 100% from $61.3K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BLACU and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Clear Street, exiting entirely with an estimated $55.6K sold.

  • 0 institutional investors held Bellevue Life Sciences Acquisition Corp. Unit (BLACU) as of Q1 2025, down from 3 in Q4 2024.
  • Funds reported $0 of Bellevue Life Sciences Acquisition Corp. Unit stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Bellevue Life Sciences Acquisition Corp. Unit positions in Q1 2025 and 3 closed out, a net change of -3 holders.
  • The largest Bellevue Life Sciences Acquisition Corp. Unit seller in Q1 2025 was Clear Street, an estimated $55.6K sold.

Based on aggregated 13F filings for Q1 2025.